Over 20,000 biopharma industry professionals converged in Boston at BIO International for four days of networking, learning and dealmaking. What did we learn? Find the top takeaways in our free, quick-read infographic.
Key BIO International 2025 Highlights:
Download the infographic now for key statistics, quotes and other BIO International 2025 highlights.
Share
Understand the context. Data-driven news and analysis for the pharma, biotech and medtech sectors.
Report/eBook
21 Apr 2026
2025 Deal-making Roundup
Video Blog
21 Apr 2026
How do Forecasting Approaches and Methodologies Change Through the Product Lifecycle?
Pharma forecasting is not a “one and done” activity. The life of a drug – from a glint…
Infographic
13 Apr 2026
2025 Deal-making Roundup Infographic
Webinar
2 Apr 2026
World Preview 2026 Webinar
The top-selling drugs and companies in 2032 The therapy areas driving growth Top pipeline products and the blockbusters…
Blog
31 Mar 2026
BIO-Europe Spring: Pharma Dealmaking in Lisbon
CNS may finally be emerging from its long discussed graveyard. Oncology dealmaking is becoming more selective. And sourcing…
Video Blog
30 Mar 2026
Highlights of the Orphan Drugs Report by its Creators
For the past few years, Melanie Senior and Andreas Hadjivasiliou have worked together to deliver Evaluate’s annual Orphan…
Video Blog
30 Mar 2026
How We Build the Analysis Behind Our Orphan Drugs Report
How do we Create the Analysis for our Orphan Drugs Report? Insight is the cornerstone of our annual…
Report/eBook
20 Mar 2026
2025 Review: Capital’s Better
Biopharma capital returned in 2025. But not for everyone. After a significant dry spell, capital began to flow…
Blog
20 Mar 2026
Three Things we Learned in our 2026 Orphan Drugs Webinar
Orphan drugs are forecast to make up 21% of all prescription drug sales by 2032, according to Evaluate…
Infographic
17 Mar 2026
2026 Orphan Drugs Infographic:
Orphan drug developers are navigating a more complex landscape. FDA decision making has proved unpredictable, and rare disease…
